DDIS-10. ENGINEERED EXOSOMES FOR GLIOMA THERAPY

Glioblastoma (GBM) is the most common among all malignant brain tumors, with 17,000 diagnoses every year in the United States. Despite receiving surgery, radiotherapy, and chemotherapy, the median survival of GBM patients is only 14.6 months, and less than 10% of GBM patients survive more than 5 yea...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Hossain, Anwar, Hasan, Irtiza, Adachi, Satoshi, Gumin, Joy, Kerrigan, Brittany, Lang, Frederick
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216546/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.289
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki